Chronic Exposure to Androgenic-Anabolic Steroids Exacerbates Axonal Injury and Microgliosis in the CHIMERA Mouse Model of Repetitive Concussion - Namjoshi, Dhananjay R.; Cheng, Wai Hang; Carr, Michael; Martens, Kris M.; Zareyan, Shahab; Wilkinson, Anna; McInnes, Kurt A.; Cripton, Peter A.; Wellington, Cheryl L. (PloS one, 2016)
Keywords: Alzheimer's disease; Anabolic Agents - pharmacology; Anabolic steroids; Androgens - pharmacology; Animals; Athletes; Atrophy; Axons - drug effects; Axons - pathology; Behavior; Binding sites; Biomechanics; Body weight; Brain; Brain Concussion - complications; Brain Concussion - pathology; Brain Injuries - complications; Brain Injuries - pathology; Brain Injury, Chronic - complications; Brain Injury, Chronic - pathology; Chronic brain injury; Chronic exposure; Chronic traumatic encephalopathy; Cognitive ability; Collaboration; Complications and side effects; Concussion; Dementia; Disease Models, Animal; Disease Progression; Dosage and administration; Drugs; Encephalopathy; Exposure; Fuel consumption; Head injuries; Health aspects; Immune response; Innate immunity; Laboratories; Localization; Male; Medicine; Methyltestosterone; Methyltestosterone - pharmacology; Mice; Mice, Inbred C57BL; Nandrolone - pharmacology; Neurodegenerative diseases; Neuropathology; Neurosciences; Nortestosterone; Pathogenesis; Pathology; Proteins; Risk factors; Serotonin S1 receptors; Steroid hormones; Steroids; Steroids - pharmacology; Substance use; Substantia alba; Tau protein; Testosterone; Testosterone - analogs & derivatives; Testosterone - pharmacology; Time Factors; Traumatic brain injury; Young adults; Canada; United States--US